|
|
||||||||
Cutting Edge |



2,*
*
Michael Heidelberger Division of Immunology, Department of Pathology and Kaplan Cancer Center,
Department of Cell Biology,
Skirball Institute of Biomolecular Medicine, Department of Pharmacology, New York University School of Medicine, New York, NY 10016
Antagonist-like engagement of the TCR has been proposed to induce T cell selection in the thymus. However, no natural TCR ligand with TCR antagonist activity is presently known. Using a combination of bioinformatics and functional testing we identified the first self-peptide that can both deliver antagonist-like signals and promote T cell selection in the thymus. The peptide is presented by appropriate MHC class I molecules in vivo. Thus, endogenous antagonist peptides exist and may be involved in TCR repertoire selection.
This article has been cited by other articles:
![]() |
T. A. Baldwin, M. M. Sandau, S. C. Jameson, and K. A. Hogquist The timing of TCR{alpha} expression critically influences T cell development and selection J. Exp. Med., July 5, 2005; 202(1): 111 - 121. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. R. Santori and S. Vukmanovic Delineation of Signals Required for Thymocyte Positive Selection J. Immunol., November 1, 2004; 173(9): 5517 - 5523. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. R. Santori, K. Holmberg, D. Ostrov, N. R. J. Gascoigne, and S. Vukmanovic Distinct Footprints of TCR Engagement with Highly Homologous Ligands J. Immunol., June 15, 2004; 172(12): 7466 - 7475. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lilic, F. R. Santori, E. G. Neilson, A. B. Frey, and S. Vukmanovic The Role of Fibroblasts in Thymocyte-Positive Selection J. Immunol., November 1, 2002; 169(9): 4945 - 4950. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |